These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7487353)

  • 1. Immunosuppressive activity of C-terminal fragments of tachykinins.
    Siemion IZ; Kubik A; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):201-3. PubMed ID: 7487353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
    Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of alanine analogs of cyclolinopeptide A.
    Wieczorek Z; Zimecki M; Pedyczak A; Lisowski M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):291-6. PubMed ID: 8010868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory activity of conformationally restricted peptides related to TGF-beta-2 90-99 sequence.
    Wieczorek Z; Słoń JJ; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):209-14. PubMed ID: 9017160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and immunosuppressive activity of glycine containing linear analogs of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Pédyczak A; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):285-9. PubMed ID: 8010867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conformational analysis of tachykinins. III. C-terminal fragment Asx-Xaa-Phe-Yaa-Gly-Leu-Met-NH2].
    Avanov AIa
    Bioorg Khim; 1991 Jul; 17(7):937-44. PubMed ID: 1793435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive mini-domain of human lactoferrin.
    Siemion IZ; Sloń J; Wieczorek Z
    J Pept Sci; 1995; 1(5):295-302. PubMed ID: 9223008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological studies on analogs of cyclolinopeptide A with a shortened peptide chain.
    Siemion IZ; Pedyczak A; Strug I; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):459-65. PubMed ID: 8572907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive activity of tyrosine analogues of cyclolinopeptide A.
    Wieczorek Z; Pedyczak A; Bodalski T; Lisowski M; Trojnar J; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):213-6. PubMed ID: 1300986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kassina senegalensis skin tachykinins: molecular cloning of kassinin and (Thr2, Ile9)-kassinin biosynthetic precursor cDNAs and comparative bioactivity of mature tachykinins on the smooth muscle of rat urinary bladder.
    Wang L; Zhou M; Lynch L; Chen T; Walker B; Shaw C
    Biochimie; 2009 May; 91(5):613-9. PubMed ID: 19298842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of analogs of tripeptide Lys-Arg-Pro with D-amino acid residues.
    Siemion IZ; Kluczyk A; Słoń JJ; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):205-7. PubMed ID: 7487354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of threonine-containing analogues of cyclolinopeptide A.
    Siemion IZ; Cebrat M; Lisowski M; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):257-61. PubMed ID: 1340179
    [No Abstract]   [Full Text] [Related]  

  • 13. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs.
    Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive activity in the series of cycloamanide peptides from mushrooms.
    Wieczorek Z; Siemion IZ; Zimecki M; Bolewska-Pedyczak E; Wieland T
    Peptides; 1993; 14(1):1-5. PubMed ID: 8441706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary structures and effects on gastrointestinal motility of tachykinins from the rainbow trout.
    Jensen J; Olson KR; Conlon JM
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R804-10. PubMed ID: 7694488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the pressor response to tachykinins in isolated perfused rat kidney.
    Chen Y; Hoover DB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1176-80. PubMed ID: 7505328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphibian tachykinin precursor.
    Li J; Liu T; Xu X; Wang X; Wu M; Yang H; Lai R
    Biochem Biophys Res Commun; 2006 Dec; 350(4):983-6. PubMed ID: 17045570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of the N-terminal portions of various tachykinins in promoting salivation.
    Higa K; Gao C; Motokawa W; Abe K
    Oral Dis; 2001 Jul; 7(4):238-45. PubMed ID: 11575875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Lys-residue deletion on the immunomodulatory activity of peptides related to immunosuppressive region of lactoferrin.
    Słoń JI; Siemion IZ; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):211-6. PubMed ID: 8744698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity analyses of bufokinin and other tachykinins at bufokinin (bNK1) receptors of the small intestine of the cane toad, Bufo marinus.
    Liu L; Murray M; Conlon JM; Burcher E
    Biochem Pharmacol; 2005 Jan; 69(2):329-38. PubMed ID: 15627485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.